Analyst Ratings for Prime Medicine (PRME)
PRME Rating Summary
PRME Price Target Summary
- Highest: $11.00 (Oppenheimer)
- Lowest: $4.25 (Citi)
- Average: $7.04
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$7.04 (+97.1%)
* Over Last 12-Mos
Rating Score: 6.9 / 10
Percentile Rank: 73%
Rating Score: 6.9 / 10
Percentile Rank: 73%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/18/2026 | BMO Capital | David Lebowitz | New Coverage | Outperform (N/A) |
9.00 (N/A) |
3.17 (3.57) |
12.62% | Details |
| 6/29/2026 | H.C. Wainwright » Updated 7/10/2026 |
Arthur He | Upgrade | Buy (Neutral) |
8.00 (N/A) |
3.43 (3.57) |
4.08% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
